You may wonder why, as an exception, this editorial is co-authored by Arthur Friedlander from UCLA Dental School, LA. Well, he is currently actively involved in a discussion of obvious importance to the DMFR community. A recently published article noted that intracranial carotid artery calcifications (ICACs) were identified in 4 (2.4%) individuals (statistics recalculated by this correspondent) who were likely nested in the oldest cohort (n=169; age range, 50–85 years) of dental school clinic attendees having cone beam CT scans, in the main for implant placement.1 Using the best available evidence at the time, the authors concluded that no referral or intervention was warranted for these individuals because a study involving 406 (mainly Caucasian) patients (males, 60%; mean age, 62 ± 14 years) with ischaemic cerebrovascular symptoms (amaurosis fugax, transient ischaemic attack, stroke) could not associate the presence or volume of ICAC (as determined by multidetector CT angiography) with the patients’ symptomatic side.2 A review of more recent research, however, demonstrates the need to refer such patients to a physician because the data demonstrate that ICAC is a risk indicator of atherosclerotic disease burden across ethnic lines in both the cerebrovascular and cardiovascular distribution of healthy and symptomatic individuals. Specifically, the results of a recent study completed in Rotterdam, Netherlands, demonstrated that ICAC evidenced on non-contrast enhanced CT was prominently associated with the concomitant presence of MRI markers of vascular brain disease in healthy individuals.3 This investigation, conducted amongst 885 community-dwelling adults (males, 49.2%; mean age, 66.7 ± 5.5 years), demonstrated that higher calcification load and volume in the ICAC were prominently associated with MRI-determined increasing volume of white matter lesions known to be associated over time with development of cognitive impairment. These findings are substantiated by a study conducted in the USA which evaluated 108 consecutive multiethnic (African-American, Hispanic, Caucasian) patients (males 46%; mean age, 57.3 ± 12 years) admitted to the stroke service at Parkland Hospital in Dallas, TX.4 The researchers noted that extensive calcification of the ICAC on head CT was associated with high-grade stenosis (greater than or equal to 50%) on follow-up catheter-based cerebral angiographic study. These findings are supported by two other studies conducted in the Republic of Korea among groups of Asian patients admitted to major medical centers with symptomatic (acute ischaemic stroke/transient ischaemic attack) cerebrovascular disease. In the first project conducted amongst 159 consecutively treated patients (males, 61%; mean age, 66 ± 12 years), the extent of ICAC calcifications (as determined by unenhanced CT) was significantly associated with MRI-demonstrated periventricular and deep white matter hyperintensities and lacunar lesions.5 In the second Korean study evaluated, 314 patients (males, 65%; mean age, 66.3 ± 12.6 years), the severity of ICAC calcification on brain CT was significantly correlated with coronary artery calcium scores as determined by CT coronary angiography among patients previously believed free of atherosclerotic heart disease.6 Atherosclerosis is a generalized process affecting multiple vascular beds with arterial calcifications associated with more advanced states of disease. Cerebral calcification is a validated risk indicator of a diffuse atherosclerotic process in cerebral circulation and coronary artery atherosclerosis. The intention of this editorial is to make oral and maxillofacial radiologists aware that ICAC is a severe incidental finding that should definitely result in referral of these patients to physicians for further evaluation.
Read full abstract